Article
Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design.
PLoS neglected tropical diseases - 1 Feb 2014
Gardner Christina L, Hritz Jozef, Sun Chengqun, Vanlandingham Dana L, Song Timothy Y, Ghedin Elodie, Higgs Stephen, Klimstra William B, Ryman Kate D
Abstract excerpt
Mosquito-borne chikungunya virus (CHIKV) is a positive-sense, single-stranded RNA virus from the genus Alphavirus, family Togaviridae, which causes fever, rash and severe persistent polyarthralgia in humans. Since there are currently no FDA licensed vaccines or antiviral therapies for CHIKV, the development of vaccine candidates is of critical importance. Historically, live-attenuated vaccines (LAVs) for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
